ALX Oncology (ALXO) is now covered by Wells Fargo & Company. They set an "overweight" rating and a $5.00 price target on the stock.
ALX Oncology (ALXO) had its "buy" rating reaffirmed by HC Wainwright. They now have a $4.00 price target on the stock.
ALX Oncology initiated with a Buy at UBS [Yahoo! Finance]
ALX Oncology (ALXO) is now covered by UBS Group AG. They set a "buy" rating and a $6.00 price target on the stock.
ALX Oncology Highlights $150M Raise, Evorpacept Breast Cancer Push and EGFR ADC ALX2004 Update [Yahoo! Finance]